NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.55B
1-Year Est. Return 16.8%
This Quarter Est. Return
1 Year Est. Return
+16.8%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.42B
AUM Growth
+$102M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
34
New
Increased
Reduced
Closed

Top Buys

1
+$21.8M
2
+$19.5M
3
+$15.6M
4
VALN
Valneva
VALN
+$13.5M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$9.34M

Top Sells

1
+$22.4M
2
+$13.7M
3
+$7.34M
4
INSM icon
Insmed
INSM
+$4.5M
5
LXEO icon
Lexeo Therapeutics
LXEO
+$3.9M

Sector Composition

1 Healthcare 48.34%
2 Technology 15.92%
3 Financials 10.18%
4 Consumer Discretionary 2.98%
5 Industrials 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LNZA icon
26
LanzaTech
LNZA
$37.8M
$4.29M 0.3%
158,148
MQ icon
27
Marqeta
MQ
$2.15B
$2.57M 0.18%
441,558
ABCL icon
28
AbCellera Biologics
ABCL
$1.1B
$2.24M 0.16%
652,529
-474,386
GLTO icon
29
Galecto
GLTO
$35.6M
$341K 0.02%
99,913
FOLD icon
30
Amicus Therapeutics
FOLD
$2.92B
– –
-2,750,000
LXEO icon
31
Lexeo Therapeutics
LXEO
$660M
– –
-1,122,581
RCKT icon
32
Rocket Pharmaceuticals
RCKT
$330M
– –
-1,100,000
VERV
33
DELISTED
Verve Therapeutics
VERV
– –
-3,000,000
KYTX icon
34
Kyverna Therapeutics
KYTX
$298M
– –
-1,850,000
1
2